Cargando…

The pK(a) Distribution of Drugs: Application to Drug Discovery

The acid-base dissociation constant (pK(a)) of a drug is a key physicochemical parameter influencing many biopharmaceutical characteristics. While this has been well established, the overall proportion of non-ionizable and ionizable compounds for drug-like substances is not well known. Even less wel...

Descripción completa

Detalles Bibliográficos
Autor principal:	Manallack, David T.
Formato:	Texto
Lenguaje:	English
Publicado:	Libertas Academica 2007
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754920/ https://www.ncbi.nlm.nih.gov/pubmed/19812734

Ejemplares similares

Applications of machine learning in computer-aided drug discovery
por: Turzo, SM Bargeen Alam, et al.
Publicado: (2022)

Versatile applications of deep eutectic solvents in drug discovery and drug delivery systems: Perspectives and opportunities
por: Hayyan, Maan
Publicado: (2023)

Paramagnetic NMR in drug discovery
por: Softley, Charlotte A., et al.
Publicado: (2020)

Emergence of Extensively Drug-Resistant ST170 Citrobacter portucalensis with Plasmids pK218-KPC, pK218-NDM, and pK218-SHV from a Tertiary Hospital, China
por: Luo, Xinhua, et al.
Publicado: (2022)

The future of molecular dynamics simulations in drug discovery
por: Borhani, David W., et al.
Publicado: (2011)

Open drug discovery in Alzheimer's disease
por: Axtman, Alison D., et al.
Publicado: (2023)

NMR in target driven drug discovery: why not?
por: Keiffer, Sébastien, et al.
Publicado: (2020)

Evolving paradigms for natural-product drug discovery
por: Cordell, Geoffrey A
Publicado: (2022)

Computational drug discovery under RNA times
por: Bernetti, Mattia, et al.
Publicado: (2022)

Benchmarking pK(a )prediction
por: Davies, Matthew N, et al.
Publicado: (2006)

An expanding role for cell biologists in drug discovery and pharmacology
por: Sorger, Peter K., et al.
Publicado: (2012)

Key drivers of biomedical innovation in cancer drug discovery
por: Huber, Margit A, et al.
Publicado: (2015)

Drug discovery and development: Role of basic biological research
por: Mohs, Richard C., et al.
Publicado: (2017)

Oligodendrocytes in a dish for the drug discovery pipeline: the risk of oversimplification
por: Baldassarro, Vito Antonio, et al.
Publicado: (2020)

Modulating biomolecular condensates: a novel approach to drug discovery
por: Mitrea, Diana M., et al.
Publicado: (2022)

Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery
por: Bennett, David A.
Publicado: (2017)

Ten simple rules to power drug discovery with data science
por: Ferrero, Enrico, et al.
Publicado: (2020)

Functional patient-derived cellular models for neuropsychiatric drug discovery
por: Lago, Santiago G., et al.
Publicado: (2021)

Accelerating antiviral drug discovery: lessons from COVID-19
por: von Delft, Annette, et al.
Publicado: (2023)

In silico pK(a) prediction
por: Körner, Robert, et al.
Publicado: (2012)

A perspective on multi-target drug discovery and design for complex diseases
por: Ramsay, Rona R., et al.
Publicado: (2018)

Mechanism of Action and Target Identification: A Matter of Timing in Drug Discovery
por: Davis, Ronald L.
Publicado: (2020)

Evolution of Support Vector Machine and Regression Modeling in Chemoinformatics and Drug Discovery
por: Rodríguez-Pérez, Raquel, et al.
Publicado: (2022)

Pushing the boundaries of behavioral analysis could aid psychiatric drug discovery
por: Sweis, Brian M., et al.
Publicado: (2022)

Progress in Inherited Retinal Disease Drug Discovery and Development: A Foundation’s Perspective
por: Yerxa, Benjamin
Publicado: (2018)

MF-SuP-pK(a): Multi-fidelity modeling with subgraph pooling mechanism for pK(a) prediction
por: Wu, Jialu, et al.
Publicado: (2023)

Has the Time Come for Predictive Computer Modeling in CNS Drug Discovery and Development?
por: Geerts, H, et al.
Publicado: (2012)

Modeling the tumor immune microenvironment for drug discovery using 3D culture
por: Lee, Joanna Y., et al.
Publicado: (2021)

Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery
por: Kwofie, Samuel K., et al.
Publicado: (2023)

Pediatric GNAO1 encephalopathies: from molecular etiology of the disease to drug discovery
por: Katanaev, Vladimir L., et al.
Publicado: (2023)

Observation of the decay $\Xi^-_b \to pK^- K^-$
por: Mathad, Abhijit
Publicado: (2017)

Perspective: The promises of a holistic view of proteins—impact on antibody engineering and drug discovery
por: Phua, Ser-Xian, et al.
Publicado: (2019)

Search for CP violation using triple product asymmetries in $\Lambda^{0}_{b}\to pK^{-}\pi^{+}\pi^{-}$, $\Lambda^{0}_{b}\to pK^{-}K^{+}K^{-}$ and $\Xi^{0}_{b}\to pK^{-}K^{-}\pi^{+}$ decays
por: Aaij, Roel, et al.
Publicado: (2018)

Ionization Constants pK(a) of Cardiolipin
por: Olofsson, Gerd, et al.
Publicado: (2013)

Machine learning meets pK (a)
por: Baltruschat, Marcel, et al.
Publicado: (2020)

Why Open Drug Discovery Needs Four Simple Rules for Licensing Data and Models
por: Williams, Antony J., et al.
Publicado: (2012)

Human-yeast genetic interaction for disease network: systematic discovery of multiple drug targets
por: Suk, Kyoungho
Publicado: (2017)

A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing
por: Cabrera-Andrade, Alejandro, et al.
Publicado: (2020)

Cancer Metabolism: New Validated Targets for Drug Discovery
por: Sotgia, Federica, et al.
Publicado: (2013)

Strategies to Address Challenges in Neuroscience Drug Discovery and Development
por: O’Donnell, Patricio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ge7dqt8qar60en74f8en1is2qn